Sequence information
DRAVP ID DRAVPc016
Name Interferon alfa-n3
Sequence
Molecular Formula Not Available
Condition/Disease HIV infections, SARS infection
Group Approved
Type Protein
Description Interferon alfa-n3 is a purified form of human interferon used to stimulate the innate antiviral response in the treatment of genital warts due to human papilloma virus. Purified, natural (n is for natural) human interferon alpha proteins (consists of 3 forms or polymorphisms including 2a, 2b and 2c). 166 residues, some are glycosylated (MW range from 16 kD to 27 kD).
Active sequence/Structure
External Links
DrugBank Accession Number DB00018
Pubchem ID 46508902
CHEMBL ID CHEMBL2109047
UNII 47BPR3V3MP
CAS Not Available
Reference 10868311
ClinicalTrails Information
| NCT Number | Study Title | Condition/Disease | Status | Phase | Sponsor |
|---|---|---|---|---|---|
| NCT00215852 | A Randomized, Dose-ranging Study of Alferon LDO in Asymptomatic HIV+ Subjects | Human Immunodeficiency Virus (HIV) Infections Treatment | Terminated | Phase 2 | AIM ImmunoTech Inc. |
| NCT00002078 | Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) Infection | Human Immunodeficiency Virus (HIV) Infections Treatment | Completed | Phase 1 | Purdue Frederick |
| NCT00215826 | Study of Alferon® LDO (Low Dose Oral) in Normal Volunteers | Severe Acute Respiratory Syndrome (SARS) Treatment | Completed | Phase 2 | AIM ImmunoTech Inc. |
